Comprehensive Characterization of the Published Kinase Inhibitor Set.
Elkins, J.M., Fedele, V., Szklarz, M., Abdul Azeez, K.R., Salah, E., Mikolajczyk, J., Romanov, S., Sepetov, N., Huang, X.P., Roth, B.L., Al Haj Zen, A., Fourches, D., Muratov, E., Tropsha, A., Morris, J., Teicher, B.A., Kunkel, M., Polley, E., Lackey, K.E., Atkinson, F.L., Overington, J.P., Bamborough, P., Moller, S., Price, D.J., Willson, T.M., Drewry, D.H., Knapp, S., Zuercher, W.J.(2016) Nat Biotechnol 34: 95
- PubMed: 26501955 
- DOI: 10.1038/nbt.3374
- Primary Citation of Related Structures:  
4USD, 4USE, 4USF - PubMed Abstract: 
Despite the success of protein kinase inhibitors as approved therapeutics, drug discovery has focused on a small subset of kinase targets. Here we provide a thorough characterization of the Published Kinase Inhibitor Set (PKIS), a set of 367 small-molecule ATP-competitive kinase inhibitors that was recently made freely available with the aim of expanding research in this field and as an experiment in open-source target validation ...